Johnson & Johnson (NYSE:JNJ) Rating Increased to Buy at UBS Group
UBS Group upgraded shares of Johnson & Johnson (NYSE:JNJ – Free Report) from a neutral rating to a buy rating in a report published on Friday, Marketbeat reports. They currently have $180.00 price objective on the stock, up from their previous price objective of $167.00. A number of other research firms also recently weighed in […]